Seed Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+892
New +$192K 0.14% 90
2026
Q1
Sell
-892
Closed -$204K 99
2025
Q4
$204K Sell
892
-22
-2% -$5.01K 0.14% 100
2025
Q3
$212K Sell
914
-464
-34% -$94.5K 0.15% 105
2025
Q2
$256K Hold
1,378
0.19% 123
2025
Q1
$289K Hold
1,378
0.24% 108
2024
Q4
$245K Hold
1,378
0.2% 126
2024
Q3
$272K Hold
1,378
0.22% 120
2024
Q2
$236K Hold
1,378
0.21% 124
2024
Q1
$249K Hold
1,378
0.24% 112
2023
Q4
$220K Hold
1,378
0.22% 125
2023
Q3
$205K Buy
+1,378
New +$202K 0.23% 126
2023
Q2
Sell
-1,378
Closed -$220K 141
2023
Q1
$220K Hold
1,378
0.25% 120
2022
Q4
$223K Buy
+1,378
New +$211K 0.26% 106

Other funds holding ABBV

Seed Wealth Management's ABBV Position: Q2 2026 in Review

Seed Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 892 shares worth $224K. The stake represents 0.14% of the portfolio and ranks #90 among its holdings. This is a return to the name: Seed Wealth Management previously reported a position in ABBV as recently as Q4 2025.

Seed Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $289K in Q1 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Seed Wealth Management held 892 shares of AbbVie worth $224K as of Q2 2026.
  • AbbVie was a new Seed Wealth Management position in Q2 2026.
  • AbbVie made up 0.14% of Seed Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Seed Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
  • Seed Wealth Management's AbbVie position peaked at $289K in Q1 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seed Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.